Sort
30,917 grants matching “tumor microenvironment”
Functional Dissection of the K27M Histone Mutation In Gliomagenesis
$334,865Oren Josh Becher · Northwestern University At Chicago · R01 · FY2018 · CA
TARGETING EXTRACELLULAR MATRIX-CANCER STEM CELL INTERACTIONS IN PANCREATIC CANCER
$334,832William H Matsui · University Of Texas At Austin · R01 · FY2020 · CA
Imaging tumor microenvironment by Optical Fiber-Tethered Simultaneous Lifetime-resolved Autofluorescence-Multiharmonic (OFT-SLAM) microscopy
$334,770Haohua Tu · University Of Illinois At Urbana-Champaign · R01 · FY2022 · CA
Research Project 2: Neuroblastoma
$334,667Dipanjan Chowdhury · Dana-Farber Cancer Inst · U54 · FY2025 · CA
Dual function of HSP70 in cytoprotection of tumor cells and generation of permissive microenvironment
$334,662Hasan Korkaya · Wayne State University · R01 · FY2024 · CA
A novel therapeutic strategy to eradicate breast cancer through Hsp90 inhibition and reduced immune tolerance
$334,662Ahmed Chadli · Augusta University · R01 · FY2024 · CA
Light-Triggered Drug Release in Primed Pancreatic Tumors
$334,565Jonathan F Lovell · State University Of New York At Buffalo · R01 · FY2015 · EB
Integrative Functional Profiling of Tumor-Derived Extracellular Vesicles
$334,554Yong Zeng · University Of Florida · R33 · FY2022 · CA
Lipid Metabolism Switch Triggers Invasive and Chemoresistant Epithelial Ovarian Cancer Phenotype
$334,546Michelle R Dawson · Brown University · R01 · FY2024 · CA
Mechanisms of cutaneous immunobiology:Skin immune organ
$334,500University Of Pittsburgh At Pittsburgh · R01 · FY2004 · AI
CD38 Pretargeted Radioimmunotherapy for Myeloma
$334,444Oliver W. Press · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
The Molecular Profile of Prostate Tumors in African-American Men
$334,423Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
TARGETING THE CXCR4-SDF1 AXIS AS THERAPY FOR RELAPSED/REFRACTORY AML
$334,400John F Dipersio · Washington University · R21 · FY2009 · CA
TARGETING THE CXCR4-SDF1 AXIS AS THERAPY FOR RELAPSED/REFRACTORY AML
$334,400John F Dipersio · Washington University · R21 · FY2010 · CA
3D-Adhesion Stromagenesis in Cancer Permissiveness
$334,387Edna Cukierman · Research Inst Of Fox Chase Can Ctr · R01 · FY2015 · CA
Determine the Functional Role Dub3 in Breast Cancer Progression and Metastasis
$334,376Binhua P Zhou · University Of Kentucky · R01 · FY2019 · CA
Novel multipronged Immunovirotherapy Approach for GBM Treatment
$334,372Evanthia Galanis · Mayo Clinic Rochester · R01 · FY2025 · CA
Polarizing Macrophages to Tumor Suppressors by Blocking Multiple CCR2 Chemokine Receptor Epitopes
$334,358Juliane Nguyen · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Mechanisms of Selective Therapeutic Synergy of PARP-inhibition and CTLA4 Blockade Engaged by Interferon-gamma in the Ovarian Tumor Microenvironment
$334,312Sarah Foster Adams · University Of New Mexico Health Scis Ctr · R37 · FY2024 · CA
The identification of human hepatocellular carcinoma metastasis genes
$334,310Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity
$334,305David C Linehan · University Of Rochester · R01 · FY2023 · CA
Project 3: Physical and Metabolic Constraints of Cancer Cell Invasion
$334,243Jan Lammerding · Cornell University · U54 · FY2018 · CA
Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy
$334,212Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
ROLE OF AMPK IN TUMOR DEVELOPMENT AND THERAPY
$334,198Keith R. Laderoute · Sri International · R01 · FY2008 · CA
Combination therapy to inhibit neuroblastoma growth
$334,173Christopher Sumeet Babu Gondi · University Of Illinois At Chicago · R01 · FY2013 · CA